产品描述信息
NR-41803?? Influenza A Virus, A/Perth/16/2009 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), NIB-64(Viruses)|Influenza A virus|Influenza A Virus, A/Perth/16/2009 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), NIB-64|-60°C or colder|WHO Collaborating Center for Surveillance, Epidemiology and Control of InfluenzaAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Influenza A Virus, A/Perth/16/2009 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), NIB-64, NR-41803."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
This item is currently in our production queue. Please allow ample time for distribution lots to be made available.
Classical reassortant derived from A/Perth/16/2009 (H3N2) and A/Puerto Rico/8/1934 (H1N1) viruses. The HA and NA proteins are from A/Perth/16/2009 (H3N2).
Influenza A virus, A/Perth/16/2009 (H3N2) was isolated from a human in Australia on April 7, 2009. The US Food and Drug Administration recommended influenza A/Perth/16/2009 (H3N2)-like viruses for use as vaccines during the 2010-2011 and 2011-2012 influenza seasons. The World Health Organization recommended influenza virus A/Perth/16/2009 (H3N2)-like viruses for use as vaccines during the 2010, 2011, and 2012 Southern Hemisphere and the 2010-2011 and 2011-2012 Northern Hemisphere influenza seasons. Sequence information is available for influenza A virus, A/Perth/16/2009 (H3N2) at the
Influenza Research Database.
Each vial contains approximately 1 mL of pooled allantoic fluid from specific pathogen free (SPF) embryonated chicken eggs infected with reassortant influenza A virus, A/Perth/16/2009 (HA, NA) x A/Puerto Rico/8/1934 (H3N2).